NCT06517992

Brief Summary

The current study aims to empower local cadres in providing care for metastatic breast cancer (mBC) patients in 2 provinces in Indonesia (Bali and Yogyakarta).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 24, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

July 24, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

July 11, 2024

Last Update Submit

July 20, 2024

Conditions

Keywords

CadreEducationCommunity empowermentIndonesiaMetastatic Breast Cancer

Outcome Measures

Primary Outcomes (1)

  • European Organization for Research and Treatment for Cancer Quality of Life Questionnaire - Breast Cancer (EORTC QLQ-BR23)

    Questionnaire to measure Quality of Life of Breast Cancer Patients. This consists of 23 items with 2 domains: symptom scales (systemic therapy side effects, upset by hair loss, Arm symptoms and Breast symptoms) and functional scale (body image, future perspective, sexual functioning, and sexual enjoyment). The questionnaire uses likert scale 1-4. The options are not at all, a little, quite a bit, and very much. An option for "Not applicable (N/A)" is also offered for an item of sexual enjoyment. This instrument has been translated to Bahasa Indonesia. The scale ranges in score from 0-100 with a higher score for the functional scale represents a high or healthy level of functioning. On the other hand, the high score for symptom scale represents frequent problems.

    2-3 months

Secondary Outcomes (3)

  • Symptom Management Self Efficacy Scale - Breast Cancer (SMSES-BC)

    2-3 months

  • Preparedness for caregiving scale (PCS)

    2-3 months

  • Resilience Scale Specific to Cancer (RS-SC-10)

    2-3 months

Study Arms (1)

Health education for cadre

EXPERIMENTAL

Health education for cadre (Health Community Volunteer) to support metastatic breast cancer patients and their family caregivers

Other: Health education for cadre (communicated project)

Interventions

The investigators perform health education to cadre in order to support their role in providing care for metastatic breast cancer living in the community using a module. The module consists of text (written information) and some videos as education medias.

Health education for cadre

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsFemale metastatic Breast cancer
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed for having breast cancer at least in stage 3B or confirm to have metastatic breast cancer
  • Live at home
  • Considered as adult (Eighteen years of age or older)

You may not qualify if:

  • \- mBC patients will be exclude when their physical condition is deteriorating or when they need hospitalization.
  • The following criteria will be applied for family caregivers:
  • Appointed by mBC patients or self-identified as family caregiver of mBC patients for at least 3 months
  • Live/not live together with mBC patients but providing care to mBC patient
  • Considered as adult (Eighteen years of age or older)
  • The local cadre in Yogyakarta and Bali who self-identified as local cadre in the community and willing to involve for assisting mBC patients. The local cadre will be excluded when they are not providing consent to involve in the current study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Primary Health Center

Yogyakarta, Special Region of Yogyakarta, 55581, Indonesia

Location

Primary Health center

Bali, Indonesia

Location

Related Publications (2)

  • Kristanti MS, Effendy C, Utarini A, Vernooij-Dassen M, Engels Y. The experience of family caregivers of patients with cancer in an Asian country: A grounded theory approach. Palliat Med. 2019 Jun;33(6):676-684. doi: 10.1177/0269216319833260. Epub 2019 Mar 27.

  • Kristanti MS, Setiyarini S, Effendy C. Enhancing the quality of life for palliative care cancer patients in Indonesia through family caregivers: a pilot study of basic skills training. BMC Palliat Care. 2017 Jan 17;16(1):4. doi: 10.1186/s12904-016-0178-4.

Related Links

MeSH Terms

Conditions

Breast NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Syahirul Alim, PhD

    Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada

    STUDY CHAIR

Central Study Contacts

Martina Sinta Kristanti, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Quasi experiment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 24, 2024

Study Start

September 1, 2024

Primary Completion

July 1, 2025

Study Completion

September 1, 2025

Last Updated

July 24, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations